JW Life Science (XKRX:234080) Capital Expenditure : ₩-8,609.24 Mil (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is JW Life Science Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

JW Life Science's cash flow for capital expenditures for the three months ended in Sep. 2024 was ₩-2,864 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-8,609.24 Mil.

JW Life Science Capital Expenditure Historical Data

The historical data trend for JW Life Science's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Life Science Capital Expenditure Chart

JW Life Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-8,356.32

-16,238.11

-19,396.15

-8,293.47

-8,266.94

JW Life Science Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Capital Expenditure	Get a 7-Day Free Trial															-2,900.92	-2,663.45	-1,574.41	-1,507.12	-2,864.26

JW Life Science Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-8,609.24 Mil.

JW Life Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Life Science Corp (XKRX:234080) » Definitions » Capital Expenditure

Traded in Other Exchanges

N/A

Address

28, Hanjin 1-gil, Songak-eup, Dangjin-si, Chungcheongnam-do, Seoul, KOR, 343-823

Website

http://www.jw-lifescience.co.kr

JW Life Science Corp develops and produces infusion solutions. Its products contents amino acids, lipids, proteins, vitamins, and minerals to patients.

JW Life Science Headlines

No Headlines